UK Regulator Puts Energies Into COVID-19 While Other Services May Take Longer
Executive Summary
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.